Rate pressure product as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: a retrospective cohort study.
Zhi-Hui JiangAbudula AierkenTing-Ting WuYing-Ying ZhengYi-Tong MaYing-Ying ZhengPublished in: BMJ open (2023)
In summary, RPP is an independent predictor of long-term prognosis in patients with CAD who underwent PCI. A higher baseline RPP before PCI increased the risk of adverse outcomes. Compared with heart rate and blood pressure alone, RPP has a higher predictive value for adverse clinical outcomes.
Keyphrases
- heart rate
- percutaneous coronary intervention
- blood pressure
- coronary artery disease
- st segment elevation myocardial infarction
- acute coronary syndrome
- acute myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- end stage renal disease
- heart rate variability
- newly diagnosed
- coronary artery bypass grafting
- ejection fraction
- atrial fibrillation
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- hypertensive patients
- skeletal muscle
- heart failure
- type diabetes
- emergency department
- left ventricular
- drug induced
- adipose tissue
- electronic health record
- adverse drug
- insulin resistance